MSSPT PEPTIDE PEN MELANO GLOW – R 1000

Dosage & Administration 

• Subcutaneous injection only. 
• Loading Phase: 1 mg (24 clicks) daily for 10 days 
• Maintenance Phase: 0.5 mg (12 clicks) every 3rd day (e.g., Monday, Thursday, Sunday) 
• Frequency: As per phase- daily during loading, then every 3rd day for maintenance
• Timing: Consistent time of day (morning or evening preferred) 

Administration Instructions 

1. Attach a sterile needle (extras available if needed). 
2. Dial your dose (e.g., 24 clicks = 1 mg for loading). 
3. Clean injection site (abdomen or thigh recommended). 
4. Inject subcutaneously. 
5. Cap pen and store properly. 
6. Use consistently and pair with sun protection, hydration, and healthy lifestyle habits. 
7. Always inspect solution: Do not use if cloudy, discoloured, or containing particles. 

Pen Duration 

• Loading Phase (1 mg/24 clicks daily): ~10 days per pen (240 + 24 = 10) 
• Maintenance Phase (0.5 mg/12 clicks every 3rd day): ~60 doses per pen (240 ÷ 12 = 20; 20 doses x 3 days = ~60 days of maintenance coverage) 

Exclusive Multi-Stage Stabilization & Preservation Technology (MSSPT) 

MSSPT is the proprietary process exclusive to Peptide Pen, engineered to safeguard structural integrity, purity, and full biological activity in a compact, ready-to–use delivery system–even under demanding climatic conditions in regions like South Africa and the UAE. 

South Africa: Protects against temperature swings (summer highs 30-36°C+), variable humidity, and oxidative stress in subtropical/semi-arid climates. 

UAE: Counters extreme desert heat (40-45°C+ daytime averages, peaks >50°C) and high coastal humidity (80-90%). 

Core Stages of MSSPT 

• Molecular Optimization: Targeted modifications enhance resilience to heat/humidity, maintaining full functionality in pre-mixed liquid form. 
• Controlled Storage Environment: Sealed cartridges block light, oxygen, and moisture; minimized headspace and advanced pen materials ensure consistency during transport or excursions. 
• Protective Auxiliary Components: Proprietary buffers maintain pH stability; high-efficacy antioxidants neutralize oxidative stress; stabilizing agents prevent aggregation or potency loss. 
• Molecular Interaction Management: Thermodynamic modelling and specialized excipients sustain solubility and block unwanted interactions during heat spikes or humidity variations. Applied Stabilization Strategies for Pen Delivery. 

Exclusively tailored for pre-mixed peptide pens, MSSPT deploys optimized antioxidant shields, precision pH buffering, and full compatibility with the dosing mechanism. This counters accelerated degradation in hot/arid climates, ensuring peptides stay uniformly potent from the first click to the last, outperforming traditional lyophilized vials that require careful cold-chain handling often impractical in South Africa or the UAE. 

Peptide Pen – Powered by Precision MSSPT 

Peptide Pen formulations set the standard for reliable delivery in challenging environments. Powered by exclusive MSSPT, each pen combines buffers, antioxidants, and proprietary agents in a compact, user-friendly injector- delivering strict control over pH, light, oxygen, oxidative factors, and moisture even under South Africa’s subtropical variability or the UAE’s extreme desert heat and humidity. No mixing, no guesswork, and reliable performance in every dose, wherever you are. 

Storage Instructions 

• Store either in refrigerator (fridge); never freeze or in a cool dry place. 
• Keep pen capped and clean. 
• Protect from light and heat. 
• After use: Same conditions. 
• Out of reach of children. 
• Discard if expired or solution appears abnormal. 

How Supplied 

Prefilled pen containing 10 mg Melanotan II solution in 2.6 mL volume (240 clicks). Manufacturer/Distributor: Peptide Pen – RSA/UAE. 

IMPORTANT NOTICE 

This product is not intended to diagnose, treat, cure, or prevent any disease. Statements have not been evaluated by the FDA, SAHPRA, or other authorities. Always consult a licensed healthcare provider before use, especially if pregnant, breastfeeding, under 18, or managing medical conditions.